bioAffinity Technologies, Inc. Investment Income, Interest
bioAffinity Technologies, Inc. (BIAF) reported Investment Income, Interest of $3.36 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-07
- bioAffinity Technologies, Inc. investment income, interest for the quarter ending 2026-06-30 was $3.36K, a 65.83% increase year-over-year.
- bioAffinity Technologies, Inc. investment income, interest for the quarter ending 2026-03-31 was $10.03K, a 1749.82% increase year-over-year.
- bioAffinity Technologies, Inc. investment income, interest for the quarter ending 2025-12-31 was $19.73K, a 384.89% increase year-over-year.
- bioAffinity Technologies, Inc. investment income, interest for the quarter ending 2025-09-30 was $1.09K, a 51.17% decline year-over-year.
- bioAffinity Technologies, Inc. investment income, interest for fiscal 2025 was $23.39K, a 32.79% increase from fiscal 2024.
- bioAffinity Technologies, Inc. investment income, interest for fiscal 2024 was $17.61K, a 85.58% decline from fiscal 2023.
- bioAffinity Technologies, Inc. investment income, interest for fiscal 2023 was $122.13K, a 161.48% increase from fiscal 2022.
- bioAffinity Technologies, Inc. investment income, interest for fiscal 2022 was $46.71K, a 10916.04% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.36K 10-Q · filed 2026-08-07 | $13.38K 10-Q · filed 2026-08-07 | $33.11K derived: sum of 3 quarters · filed 2026-08-07 | $34.20K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $10.03K 10-Q · filed 2026-05-11 | $29.76K derived: sum of 2 quarters · filed 2026-05-11 | $30.84K derived: sum of 3 quarters · filed 2026-05-11 | $32.87K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $19.73K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $20.82K derived: sum of 2 quarters · filed 2026-03-16 | $22.84K derived: sum of 3 quarters · filed 2026-08-07 | $23.39K 10-K · filed 2026-03-16 | ||
| 2025-09-30 | $1.09K 10-Q · filed 2025-11-14 | $3.11K derived: sum of 2 quarters · filed 2026-08-07 | $3.65K 10-Q · filed 2025-11-14 | $7.72K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | $2.02K 10-Q · filed 2026-08-07 | $2.57K 10-Q · filed 2026-08-07 | $6.64K derived: sum of 3 quarters · filed 2026-08-07 | $8.86K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $542.00 10-Q · filed 2026-05-11 | $4.61K derived: sum of 2 quarters · filed 2026-05-11 | $6.84K derived: sum of 3 quarters · filed 2026-05-11 | $12.03K derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2024-12-31 | $4.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $6.30K derived: sum of 2 quarters · filed 2026-03-16 | $11.48K derived: sum of 3 quarters · filed 2026-03-16 | $17.61K 10-K · filed 2026-03-16 | ||
| 2024-09-30 | $2.23K 10-Q · filed 2025-11-14 | $7.41K derived: sum of 2 quarters · filed 2025-11-14 | $13.54K 10-Q · filed 2025-11-14 | $25.70K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $5.19K 10-Q · filed 2025-08-14 | $11.31K 10-Q · filed 2025-08-14 | $23.47K derived: sum of 3 quarters · filed 2025-08-14 | $50.67K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $6.13K 10-Q · filed 2025-05-15 | $18.29K derived: sum of 2 quarters · filed 2025-05-15 | $45.48K derived: sum of 3 quarters · filed 2025-05-15 | $89.60K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $12.16K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $39.35K derived: sum of 2 quarters · filed 2025-03-31 | $83.48K derived: sum of 3 quarters · filed 2025-03-31 | $122.13K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $27.19K 10-Q · filed 2024-11-14 | $71.32K derived: sum of 2 quarters · filed 2024-11-14 | $109.97K 10-Q · filed 2024-11-14 | $148.42K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $44.12K 10-Q · filed 2024-08-14 | $82.78K 10-Q · filed 2024-08-14 | $121.22K derived: sum of 3 quarters · filed 2024-08-14 | $128.64K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $38.65K 10-Q · filed 2024-05-15 | $77.10K derived: sum of 2 quarters · filed 2024-05-15 | $84.52K derived: sum of 3 quarters · filed 2024-05-15 | $84.79K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $38.45K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $45.86K derived: sum of 2 quarters · filed 2024-04-01 | $46.14K derived: sum of 3 quarters · filed 2024-04-01 | $46.71K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $7.41K 10-Q · filed 2023-11-14 | $3.00 10-Q · filed 2022-11-14 | $7.69K derived: sum of 2 quarters · filed 2023-11-14 | $8.26K 10-Q · filed 2023-11-14 | $850.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $276.00 10-Q · filed 2023-08-14 | $847.00 10-Q · filed 2023-08-14 | ||||
| 2021-12-31 | $400.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $419.00 derived: sum of 2 quarters · filed 2023-03-31 | $424.00 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $19.00 10-Q · filed 2022-11-14 | $24.00 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |